Bolt Biotherapeutics annual operating margin
2020
2021
2022
2023
2024
2025
Bolt Biotherapeutics Operating Margin Growth & History (BOLT)
Bolt Biotherapeutics's operating margin was −469.30% for fiscal 2025.
View full Bolt Biotherapeutics company overviewBolt Biotherapeutics annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −469.30% | +480.60 pp |
| 2024 | 2024-12-31 | −949.91% | +17.54 pp |
| 2023 | 2023-12-31 | −967.45% | +609.11 pp |
| 2022 | 2022-12-31 | −1,576.56% | +5787.57 pp |
| 2021 | 2021-12-31 | −7,364.13% | +13926.78 pp |
| 2020 | 2020-12-31 | −21,290.91% | — |
Bolt Biotherapeutics quarterly operating margin
Q1.20
Q2.20
Q3.20
Q3.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −167,480.00% | −166969.47 pp |
| Q1 2026 | 2026-03-31 | −29,234.62% | −28243.21 pp |
| Q4 2025 | 2025-12-31 | −283.40% | +1157.70 pp |
| Q3 2025 | 2025-09-30 | −355.14% | +1417.17 pp |
| Q2 2025 | 2025-06-30 | −510.53% | −186.45 pp |
| Q1 2025 | 2025-03-31 | −991.41% | −45.21 pp |
| Q3 2024 | 2024-09-30 | −1,441.10% | −721.84 pp |
| Q2 2024 | 2024-06-30 | −1,772.31% | −388.36 pp |
| Q1 2024 | 2024-03-31 | −324.08% | +684.41 pp |
| Q4 2023 | 2023-12-31 | −946.19% | +544.95 pp |
| Q3 2023 | 2023-09-30 | −719.26% | +338.79 pp |
| Q2 2023 | 2023-06-30 | −1,383.95% | +271.40 pp |
| Q1 2023 | 2023-03-31 | −1,008.49% | +1928.29 pp |
| Q4 2022 | 2022-12-31 | −1,491.14% | +1637.32 pp |
| Q3 2022 | 2022-09-30 | −1,058.05% | +17456.88 pp |
| Q2 2022 | 2022-06-30 | −1,655.35% | +14926.74 pp |
| Q1 2022 | 2022-03-31 | −2,936.78% | +2395.54 pp |
| Q3 2021 | 2021-09-30 | −3,128.46% | — |
| Q3 2020 | 2020-09-30 | −18,514.93% | — |
| Q2 2020 | 2020-06-30 | −16,582.09% | — |
| Q1 2020 | 2020-03-31 | −5,332.32% | — |
Bolt Biotherapeutics operating margin trends
Over the last five reported fiscal years, Bolt Biotherapeutics's operating margin increased from −21,290.91% to −469.30%, a change of +20821.60 percentage points. The latest reported quarter, Q2 2026, shows −167,480.00%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bolt Biotherapeutics filings at SEC.gov ↗